Meeting Report: 2015 PDA Virus & TSE Safety Forum

References

1. 1.↵
   Workshop on viral safety of plasma-derived medicinal products with respect to hepatitis E virus. 28–29 October 2015, European Medicines Agency, London http://www.ema.europa.eu
2. 2.↵
   EMA/CHMP/BWP/723009/2014: Reflection paper on viral safety of plasma-derived medicinal products with respect to hepatitis E virus. End of consultation (deadline for comments) 30 September 2015 http://www.ema.europa.eu
3. 3.↵
   EMA/CHMP/BWP/548524/2008. Rev 1: Guideline on epidemiological data on blood transmissible infections. End of consultation (deadline for comments) 31 August 2015 http://www.ema.europa.eu
4. 4.↵
   EMA/CHMP/BWP/26802/2012 Guideline on the adventitious agent safety of urine-derived medicinal products. 26 May 2015 http://www.ema.europa.eu
5. 5.↵
   Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC OJ L158 of 27 May 2014, pp 1–76.
6. 6.↵
   EMA/CHMP/BWP/398498/2005 Guideline on virus safety evaluation of biotechnological investigational medicinal products, http://www.ema.europa.eu
7. 7.↵
   1. Ma H.,
   2. Galvin T. A.,
   3. Glasner D. R.,
   4. Shaheduzzaman S.,
   5. Khan A. S.

   Identification of a novel rhabdovirus in Spodoptera frugiperda cell lines. J. Virol. 2014, 88 (12), 6576–6585.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. Pfaender S.,
   2. Brown R. J. P.,
   3. Pietschmann T.,
   4. Steinmann E.

   Natural reservoirs for homologs of hepatitis C virus. Emerg. Microbes Infect. 2014, 3 (3), e21.

   OpenUrlCrossRef
9. 9.↵
   1. Miesegaes G.,
   2. Lute S.,
   3. Brorson K.

   Analysis of viral clearance unit operations for monoclonal antibodies. Biotechnol. Bioeng. 2010, 106 (2), 238–246.

   OpenUrlPubMed
10. 10.↵
    IDT Biologika GmbH, Dessau-Rosslau Germany, website: http://www.idt-biologika.de/index.php?lang=2.
11. 11.↵
    1. Chen C.-C.,
    2. Wang Y.-H.

    Estimation of the exposure of the UK population to the bovine spongiform encephalopathy agent through dietary intake during the period 1980 to 1996. PLoS one 2014, 9 (4), e94020.

    OpenUrlPubMed